14May
Pediatric Vaccine Study
Currently enrolling for Pediatric Vaccine Study
Do you have a newborn or are about to have a baby? Premier Medical Group is starting a research study testing a Meningococcal B vaccine in infants.
Qualifications:
- Healthy babies born full term (≥ 38 weeks)
- Babies ages 6 to 12 weeks of age
- Babies cannot have received previous vaccines.
(One (1) dose of HBV at birth is allowed.)
Benefits:
- Study vaccine, other infant vaccines and office visits provided at no charge
- Compensation for time and travel
